GlaxoSmithKline Pharmaceuticals share news and announcements
NSE: GLAXOBSE: 500660Pharmaceuticals & BiotechnologyMid Cap
Formerly Glaxo (India)
Last close ₹2,404.70down ₹29.00 (1.19%)BSE ₹2,404.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹2,433.70.
52-week range of traded prices to 23 Oct 2026
₹2,088.10Low, 12 Jun 2026₹3,120.70High, 28 Aug 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹40,737 Cr221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 3 Aug 2026
- 38.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 13 May 2026
- 18.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.37%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 3 Aug 2026
- 50.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 3 Aug 2026
- 56.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 56,17458.6% delivered
GlaxoSmithKline Pharmaceuticals dividends
33 filed, newest first.
May 2026
May 2025
Oct 2024
May 2024
17 May · Dividend
May 2023
17 May · Dividend
May 2022
May 2021
18 May · Dividend
Jun 2020
15 Jun · Dividend
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
18 May · Dividend
Board of Directors of the Company at its meeting held on May 18, 2015 have recommended the payment of a Dividend of Rs. 62.50 per equity share for the fifteen month period ended March 31, 2015. The dividend if approved by the shareholders will be paid on or after August 01, 2015.
Feb 2014
18 Feb · Dividend
Dividend will be payable on or after April 19, 2014.18 Feb · Dividend
Board of Directors of the Company at its meeting held on February 18, 2014 have recommended the payment of a Dividend of Rs. 50/- per equity share for the year ended December 31, 2013.
Feb 2013
19 Feb · Dividend
Dividend will be payable on April 17, 2013.19 Feb · Dividend
Board of Directors of the Company at its meeting held on February 19, 2013 has recommended a dividend of Rs. 50/- per equity share (Previous year: Rs 45 per equity share)
Feb 2012
16 Feb · Dividend
Board of Directors of the Company at its meeting held on February 16, 2012 have recommended a dividend of Rs. 45/- per equity share for the year ended December 31, 2011.
Feb 2011
14 Feb · Dividend
Board of Directors of the Company at its meeting held on February 14, 2011 have recommended the payment of a Dividend of Rs. 40/- per equity share for the year ended December 31, 2010.
Feb 2010
15 Feb · Dividend
At the meeting of the Board of Directors of the Company held on February 15, 2010 the Directors have recommended the payment of Dividend of Rs.30/- per equity share for the year ended December 31, 2009.
Feb 2009
18 Feb · Dividend
At the meeting of the Board of Directors held on February 18, 2009 the directors have recommended the payment of a Dividend of Rs. 22/- per equity share for the year ended December 31, 2008. The Directors are also pleased to recommend a special additional Dividend of Rs. 18/- per equity share.
Feb 2008
22 Feb · Dividend
Board of Directors of the Company in its meeting held on February 22, 2008 have recommended the payment of a Dividend of Rs. 18/- per equity share for the year ended December 31, 2007. The Directors are also pleased to recommend a special additional dividend of Rs.18/- per equity share.
Feb 2007
19 Feb · Dividend
The dividend will be payable on or after 30th March 200716 Feb · Dividend
Board of Directors at their meeting held on February 16,2007, have recommended the payment of a Dividend of Rs. 17 per equity share for the year ended December 31,2006. The Directors have also recommended a special additional dividend of Rs. 14 per equity share.